SPRO – spero therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

SPRO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/26

04:05 pm

spro

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Low Report

Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update

Report

3/18

04:05 pm

spro

Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

Low Report

Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

Report

2/11

08:51 am

spro

Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy [Seeking Alpha]

Medium Report

Spero Therapeutics: Tebipenem's FDA Path Supports A Speculative Buy [Seeking Alpha]

Report

1/24

05:10 am

spro

Spero Therapeutics (NASDAQ:SPRO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Neutral Report

Spero Therapeutics (NASDAQ:SPRO) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Report

1/11

01:03 am

spro

Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Wall Street

Low Report

Spero Therapeutics (NASDAQ:SPRO) was upgraded by analysts at Wall Street

Report

1/3

01:08 am

spro

Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Wall Stre

Low Report

Spero Therapeutics (NASDAQ:SPRO) was downgraded by analysts at Wall Stre

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.